Temasek Holdings Sees Strong Returns From Recent Indian IPOs
· Business · CNBC, Economic Times
Singapore-based state investor Temasek Holdings has recorded significant gains from three recent Indian market debuts, with shares of Shiprocket, Milky Mist, and Molbio Diagnostics trading well above their IPO prices. Shiprocket shares rose nearly 50% after its listing, while Milky Mist and Molbio Diagnostics also saw substantial premiums following their market entries. Temasek, which has deployed approximately $9 billion in India over the past three years, maintains a stake of over 5% in both Shiprocket and Milky Mist. This performance contrasts with broader trends, as other foreign investors have remained net sellers of Indian equities throughout much of this year. The sovereign wealth fund continues to view India as its best-performing market on a 10-year basis.
Why it matters
Temasek's continued capital deployment signals sustained institutional confidence in the Indian startup and equity ecosystem, even as other global fund managers express concerns over high valuations and growth.
Read the original report — CNBC
Join us on Telegram
Breaking news the moment it lands. At 10,000 members we ship the Android app.